Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

por Xun, Zhen, Yao, Xiaobao, Ou, Qishui
Publicado 2023

The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks...

por Lin, Sheng, Fu, Ya, Wu, Wennan, Chen, Tianbin, Chen, Ningdai, Xun, Zhen, Liu, Can, Ou, Qishui, Zeng, Yongbin, Huang, Huanhuan
Publicado 2020

Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression

por Lin, Caorui, Huang, Ying, Luo, Linjie, Fang, Fengling, Zhang, Jiawei, Xun, Zhen, Fu, Ya, Shang, Hongyan, Liu, Can, Ou, Qishui
Publicado 2022

IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro

por Xu, Siyi, Huang, Jinlan, Xun, Zhen, Li, Shiqi, Fu, Ya, Lin, Ni, Wu, Wennan, Chen, Tianbin, Liu, Can, Ou, Qishui
Publicado 2022

Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach

por Xun, Zhen, Yao, Xiaobao, Zhu, Chenggong, Ye, Yuchen, Wu, Songhang, Chen, Tianbin, Zeng, Yongbin, Lin, Caorui, Yang, Bin, Ou, Qishui, Liu, Can
Publicado 2022

Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon‐α monotherapy

por Shang, Hongyan, Hu, Yuhai, Guo, Hongyan, Lai, Ruimin, Fu, Ya, Xu, Siyi, Zeng, Yongbin, Xun, Zhen, Liu, Can, Wu, Wennan, Guo, Jianhui, Ou, Qishui, Chen, Tianbin
Publicado 2022

Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8(+) T and NK cell function

por Xun, Zhen, Lin, Jinpiao, Yu, Qingqing, Liu, Can, Huang, Jinlan, Shang, Hongyan, Guo, Jianhui, Ye, Yuchen, Wu, Wennan, Zeng, Yongbin, Wu, Songhang, Xu, Siyi, Chen, Tianbin, Chen, Jing, Ou, Qishui
Publicado 2021